Skip to content
Super Fortune Hub

Social Media Influencers Fueling Parallel Trade for Unapproved Slimming Medication

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Treatment Acquiring Traction Online

Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these profiles privately for supplier links, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with numerous of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers market the drug there before directing customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Experts Express Concerns

However, physicians and chemists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals injecting products of unknown origin.

Some experts stated the popularity for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still violate medicines, advertising, and consumer laws, risking fines, legal action or imprisonment.

Service Response and Content Elimination

Based on the social media company, the platform has removed violative content and banned related keywords and search suggestions. The company said it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.

Digital Marketplace Operations

Research also discovered communities with up to nine thousand members selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with numerous of users, populated with photos of slimming results, glowing reviews and step-by-step guides for preparing or administering at home.

Within moments of entering one community, a seller shared WhatsApp details, where the majority of transactions occur. The seller sent an guidebook and promised shipping within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, health issues or past usage.

Product Information and Costs

Within these communities, messages display black plastic parcels with postal service labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with purified liquid, or pre-filled pens typically sold at £160 for 20mg. When asked how much time a injector should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service said it regularly monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they cannot confirm. Even if the science behind retatrutide is valid, these online versions may not include what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has already seen individuals harmed by personal administration from unverified sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject users to possibly significant health risks”.

About the author

Danielle Alvarado

Elena Voss is a seasoned financial analyst and writer with over a decade of experience in wealth management.

Super Fortune Hub

Type to search articles.